Impact of infliximab on serum leptin levels in patients with Crohn's disease

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 6, 2005, Pages 3510-3516

  Franchimont, Denis ^a,b   Roland, Sandrine ^a   Gustot, Thierry ^a   Quertinmont, Eric ^a   Toubouti, Youssef ^b   Gervy, Marie Christine ^a   Deviere, Jacques ^a   Van Gossum, Andre ^a  

^a ERASME HOSPITAL   (Belgium)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HYDROCORTISONE; INFLIXIMAB; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 6; LEPTIN; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2; BIOLOGICAL MARKER; MONOCLONAL ANTIBODY;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DOWN REGULATION; FEMALE; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE RELEASE; HYDROCORTISONE URINE LEVEL; IN VIVO STUDY; MALE; MASS; MEASUREMENT; MEDIATOR; MOLECULE; PATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REMISSION; TIME; WEIGHT GAIN; BLOOD; BODY MASS; DRUG EFFECT; PHYSIOLOGY; REGRESSION ANALYSIS;

ADULT; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; BODY MASS INDEX; CROHN DISEASE; FEMALE; HUMANS; INTERLEUKIN-6; LEPTIN; MALE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REGRESSION ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT GAIN;

EID: 21244432426     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2004-1222     Document Type: Article

References (40)

1. Beutler B, Greenwald D, Hulmes JD, Chang M, Pan YC, Mathison J, Ulevitch R, Cerami A 1985 Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316:552-554
2. Argiles JM, Lopez-Soriano J, Busquets S, Lopez-Soriano FJ 1997 Journey from cachexia to obesity by TNF. FASEB J 11:743-751
3. Spiegelman BM, Flier JS 2001 Obesity and the regulation of energy balance. Cell 104:531-543
4. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F 1995 Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540-543
5. Friedman JM, Halaas JL 1998 Leptin and the regulation of body weight in mammals. Nature 395:763-770
6. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS 1997 Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 100:2777-2782
7. Barbier M, Cherbut C, Aube AC, Blottiere HM, Galmiche JP 1998 Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats. Gut 43:783-790
8. Bornstein SR, Licinio J, Tauchnitz R, Engelmann L, Negrao AB, Gold P, Chrousos GP 1998 Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab 83:280-283
9. Zumbach MS, Boehme MW, Wahl P, Stremmel W, Ziegler R, Nawroth PP 1997 Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab 82:4080-4082
10. Fawcett RL, Waechter AS, Williams LB, Zhang P, Louie R, Jones R, Inman M, Huse J, Considine RV 2000 Tumor necrosis factor-α inhibits leptin production in subcutaneous and omental adipocytes from morbidly obese humans. J Clin Endocrinol Metab 85:530-535
11. Bruun JM, Pedersen SB, Kristensen K, Richelsen B 2002 Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol Cell Endocrinol 190:91-99
12. Ballinger A, Kelly P, Hallyburton E, Besser R, Farthing M 1998 Plasma leptin in chronic inflammatory bowel disease and HIV: implications for the pathogenesis of anorexia and weight loss. Clin Sci (Lond) 94:479-483
13. Ballinger A 1999 Divergency of leptin response in intestinal inflammation. Gut 44:588-589
14. van Crevel R, Karyadi E, Netea MG, Verhoef H, Nelwan RH, West CE, van der Meer JW 2002 Decreased plasmaleptin concentrations in tuberculosis patients are associated with wasting and inflammation. J Clin Endocrinol Metab 87:758-763
15. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ 1997 Ashort-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 337:1029-1035
16. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, van Deventer SJ 1999 Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 340:1398-1405
17. Rutgeerts P, D'Haens G, Targan S, Vasiliauskas E, Hanauer SB, Present DH, Mayer L, Van Hogezand RA, Braakman T, DeWoody KL, Schaible TF, Van Deventer SJ 1999 Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology 117:761-769
18. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P; ACCENT I Study Group 2002 Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 359:1541-1549
19. Lennard-Jones JE 1989 Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2-6; discussion 16-19
20. Harrison J, Hanauer SB 2002 Medical treatment of Crohn's disease. Gastroenterol Clin North Am 31:167-184
21. Sandborn WJ, Hanauer SB 2002 Infliximab in the treatment of Crohn's disease: a user's guide for clinicians. Am J Gastroenterol 97:2962-2972
22. Considine RV, Nyce MR, Kolaczynski JW, Zhang PL, Ohannesian JP, Moore Jr JH, Fox JW, Caro JF 1997 Dexamethasone stimulates leptin release from human adipocytes: unexpected inhibition by insulin. J Cell Biochem 65:254-258
23. Papaspyrou-Rao S, Schneider SH, Petersen RN, Fried SK 1997 Dexamethasone increases leptin expression in humans in vivo. J Clin Endocrinol Metab 82:1635-1637
24. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR 2000 A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6:8-15
25. Segal KR, Burastero S, Chun A, Coronel P, Pierson Jr RN, Wang J 1991 Estimation of extracellular and total body water by multiple-frequency bioelectrical-impedance measurement. Am J Clin Nutr 54:26-29
26. Fraunberger P, Pilz G, Cremer P, Werdan K, Walli AK 1998 Association of serum tumor necrosis factor levels with decrease of cholesterol during septic shock. Shock 10:359-363
27. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, et al 1996 Serum immunoreactiveleptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295
28. Chrousos GP 1995 The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351-1362
29. Faggioni R, Feingold KR, Grunfeld C 2001 Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J 15:2565-2571
30. Palacio A, Lopez M, Perez-Bravo F, Monkeberg F, Schlesinger L 2002 Leptin levels are associated with immune response in malnourished infants. J Clin Endocrinol Metab 87:3040-3046
31. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S, Lechler RI, DePaoli AM, O'Rahilly S 2002 Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110:1093-1103
32. Grunfeld C 2002 Leptin and the immunosuppression of malnutrition. J Clin Endocrinol Metab 87:3038-3039
33. Eckert ED, Pomeroy C, Raymond N, Kohler PF, Thuras P, Bowers CY 1998 Leptin in anorexia nervosa. J Clin Endocrinol Metab 83:791-795
34. Grinspoon S, Gulick T, Askari H, Landt M, Lee K, Anderson E, Ma Z, Vignati L, Bowsher R, Herzog D, Klibanski A 1996 Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab 81:3861-3863
35. Rosenbaum M, Leibel RL, Hirsch J 1997 Obesity. N Engl J Med 337:396-407
36. Rosenbaum M, Nicolson M, Hirsch J, Murphy E, Chu F, Leibel RL 1997 Effects of weight change on plasma leptin concentrations and energy expenditure. J Clin Endocrinol Metab 82:3647-3654
37. Weigle DS, Duell PB, Connor WE, Steiner RA, Soules MR, Kuijper JL 1997 Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab 82:561-565
38. Boden G, Chen X, Mozzoli M, Ryan I 1996 Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 81:3419-3423
39. Landt M, Horowitz JF, Coppack SW, Klein S 2001 Effect of short-term fasting on free and bound leptin concentrations in lean and obese women. J Clin Endocrinol Metab 86:3768-3771
40. Al Jaouni R, Filippi J, Shneider SM, Arab K, Rampal P, Hebuterne X 2002 Effect of a chimeric anti-TNFα monoclonal antibody on energy metabolism and substrate oxidation in patients with Crohn's disease. Clin Nutr 22:28-29